Quick Answer
Pharmagreen Biotech Inc. reported Total Assets of $209.0 thousand for the year ending 2022.
- Pharmagreen Biotech Inc. showed a decrease of -44.0% in Total Assets from 2021 to 2022.
- This data is from Pharmagreen Biotech Inc.'s annual report (Form 10-K), filed with the SEC on January 17, 2023.
- XBRL data for this metric is available from 2018 to 2022 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: $595.6 thousand | Q4 2019: $605.6 thousand | Q1 2020: $804.5 thousand | Q2 2020: $817.2 thousand | Q1 2021: $13.8 thousand | Q2 2021: $19.3 thousand | Q4 2021: $357.8 thousand | Q1 2022: $198.4 thousand | Q2 2022: $191.2 thousand | Q3 2022: $209.0 thousand | Q4 2022: $211.7 thousand | Q1 2023: $163.0 thousand | Q2 2023: $140.3 thousand.
- Over the full 5 years of available data (2018 to 2022), Pharmagreen Biotech Inc.'s Total Assets has declined by 53.5%.
- Historical annual values: Fiscal year 2022: $209.0 thousand | Fiscal year 2021: $373.1 thousand | Fiscal year 2020: $266.2 thousand | Fiscal year 2019: $630.3 thousand | Fiscal year 2018: $449.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: